FURACIN
LOE ApproachingNDATOPICALOINTMENT
Approved
Oct 1945
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FURACIN is a topical ointment containing nitrofurazone, a broad-spectrum antimicrobial agent approved since 1945 for treating infected wounds and burns. It works by inhibiting bacterial enzymes and disrupting cellular metabolism. The drug is used primarily in wound care and burn management settings.
LOE Approaching
LOE approaching with moderate competitive pressure (30/100) suggests small, stable brand team focused on defending market share in specialty wound care.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on FURACIN offers stable, defensive brand management experience in a mature specialty product with established clinical value. Career growth may be limited by LOE trajectory, making this role best suited for professionals seeking to deepen wound care expertise or transition to market access and outcomes roles.
Brand ManagerMedical Science Liaison
Worked on FURACIN at Takeda? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.